Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence

Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence

US Patent 5192751 · Granted Mar 9, 1993

Estimated economic value: $35,390,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for inducing defecation2022
Method of treating voiding dysfunction2021
Compositions and methods for inducing urinary voiding and defecation2018
Benzazepine compound2017
Benzazepine compound2015
Methods of using rapid-onset selective serotonin reuptake inhibitors for treatin2010
Methods of using ziconotide to treat overactive bladder2008
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower ur2007
Method of treating nausea, vomiting, retching or any combination thereof2006
Methods for treating lower urinary tract disorders and the related disorders vul2006
1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and2005
Methods of treating or preventing interstitial cystitis2000